Overview

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

Status:
Recruiting

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

Study of hysteroscopic repeat curettage as the first-line treatment in low-risk postmolar gestational trophoblastic neoplasia compared with the MTX single drug chemotherapy

Phase:

Phase 3

Details

Lead Sponsor:

Women's Hospital School Of Medicine Zhejiang University

Collaborators:

Huazhong University of Science and Technology
Qilu Hospital of Shandong University
Sun Yat-sen University

Treatments:

Methotrexate